BRAF inhibitor

Biotech Novellus snaps up BRAF cancer drug from Daiichi's biotech unit Plexxikon
Fierce Biotech
Wed, 06/3/20 - 11:33 pm
Novellus
Plexxikon
BRAF inhibitor
PLX8394
How Far Into the Drug Pipeline Should the FTC Reach?
TheStreet.com
Mon, 05/1/17 - 10:59 am
FTC
GSK
Novartis
BRAF inhibitor
MEK inhibitor
melanoma
Array Biopharma
M&A
Novartis AG wins approval to buy GSK cancer drugs with conditions
Yahoo/Reuters
Mon, 02/23/15 - 06:00 pm
Novartis
GSK
cancer
BRAF inhibitor
MEK inhibitor
Roche and Exelixis roll toward FDA approval with a melanoma cocktail
Fierce Biotech
Thu, 02/19/15 - 10:41 am
Roche
Exelixis
FDA
melanoma
Cobimetinib
Zelboraf
BRAF inhibitor
GlaxoSmithKline Begins Phase 3 Melanoma Study
Motley Fool
Mon, 02/4/13 - 11:24 am
GSK
melanoma
BRAF inhibitor
dabrafenid
MEK inhibitor
trametinib
Roche licenses vemurafenib to Chugai
Pharmaceutical Business Review
Mon, 08/15/11 - 12:25 pm
Roche
vemurafenib
Chugai
melanoma
BRAF inhibitor
Skin-Cancer Drug Uses Genetics
WSJ Online
Tue, 06/2/09 - 10:25 pm
skin cancer
genetics
Roche
BRAF inhibitor